#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune myositis Lennox-Gastaut syndrome Ductal adenocarcinoma of pancreas Gestational trophoblastic tumour Vaginal cancer Soft tissue necrosis Mantle cell lymphoma recurrent Hypocalcaemia Ovarian cancer Pulmonary tuberculosis Hepato-lenticular degeneration Interstitial lung disease Pituitary-dependent Cushing's syndrome Idiopathic pulmonary fibrosis Homocystinuria More trials…

    Learn about Rare Diseases

    Lymphangioma – Trials in Disease Hairy cell leukaemia Soft tissue sarcoma Vascular malformation – Basic Information Urea cycle disorder – Life with Disease SAPHO syndrome – Life with Disease Haemophilia A without inhibitors – Life with Disease Atypical teratoid/rhabdoid tumour of CNS Antisynthetase syndrome – Diagnostics Systemic sclerosis pulmonary – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Camonsertib Levomepromazine Hydrochloride Eptinezumab Xp-Dc+Tl+Klh Biotin Specific Nucleic Acid Sna-Ebv Valiltramiprosate 4-IODOPHENYLALANINE I-131 Benzylpenicillin Mps-215 Morf-057 Forimtamig Opevesostat Tosilate Sotrovimab Ceftazidime Pentahydrate VIPOGLANSTAT VOTOPLAM Tominersen Ethambutol Hydrochloride Valemetostat Tosilate More therapies…

    Learn about Your Condition

    Immune system disorder Tumour of ampulla of Vater Peyronie's disease Sinusitis bacterial Myocardial ischaemia Hyperglycaemia Graves' disease Neurodevelopmental disorder Herpes simplex reactivation Rett syndrome Electronic cigarette user Alcoholism Escherichia infection Cervical dysplasia Nephroblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Aspirin for Preventing Preeclampsia in Twin Pregnancies

    Recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    Austria Belgium Bulgaria Czechia Denmark Germany +3
  • Study on Semaglutide for Reducing Mucositis in Patients Undergoing High-Dose Chemotherapy with Stem Cell Transplantation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Semaglutide
    Denmark
  • Study Comparing Ebastine and Mebeverine for Treating Irritable Bowel Syndrome in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Investigated Drugs:
    • Ebastine
    • Mebeverine Hydrochloride
    Belgium
  • Study on Patient-Controlled Sedation with Propofol for Women Undergoing Repair of Obstetric Perineal Tears Using Ropivacaine, Lidocaine, and Mepivacaine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Anhydrous Ropivacaine Hydrochloride
    • Mepivacaine Hydrochloride
    Sweden
  • Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pegfilgrastim
    • Acalabrutinib
    • Prednisolone
    Germany Greece
  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Methylprednisolone Hemisuccinate
    • Cyclophosphamide Monohydrate
    Belgium France
Previous Page
1 … 580 581 582 583 584 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!